首页> 外文期刊>Nutrition >Comparison of the anticatabolic effects of leucine and Ca-β-hydroxy-β-methylbutyrate in experimental models of cancer cachexia
【24h】

Comparison of the anticatabolic effects of leucine and Ca-β-hydroxy-β-methylbutyrate in experimental models of cancer cachexia

机译:亮氨酸和Ca-β-羟基-β-甲基丁酯在癌症癌症癌症实验模型中的抗真实效应的比较

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: Loss of skeletal muscle is the most debilitating feature of cancer cachexia, and there are few treatments available. The aim of this study was to compare the anticatabolic efficacy of L-leucine and the leucine metabolite β-hydroxy-β-methylbutyrate (Ca-HMB) on muscle protein metabolism, both invitro and invivo. Methods: Studies were conducted in mice bearing the cachexia-inducing murine adenocarcinoma 16 tumor, and in murine C2 C12 myotubes exposed to proteolysis-inducing factor, lipopolysaccharide, and angiotensin II. Results: Both leucine and HMB were found to attenuate the increase in protein degradation and the decrease in protein synthesis in murine myotubes induced by proteolysis-inducing factor, lipopolysaccharide, and angiotensin II. However, HMB was more potent than leucine, because HMB at 50 μM produced essentially the same effect as leucine at 1 mM. Both leucine and HMB reduced the activity of the ubiquitin-proteasome pathway as measured by the functional (chymotrypsin-like) enzyme activity of the proteasome in muscle lysates, as well as Western blot quantitation of protein levels of the structural/enzymatic proteasome subunits (20 S and 19 S) and the ubiquitin ligases (MuRF1 and MAFbx). Invivo studies in mice bearing the murine adenocarcinoma 16 tumor showed a low dose of Ca-HMB (0.25 g/kg) tobe 60% more effective than leucine (1 g/kg) in attenuating loss of body weight over a 4-d period. Conclusion: These results favor the clinical feasibility of using Ca-HMB over high doses of leucine for the treatment of cancer cachexia.
机译:目的:骨骼肌的丧失是癌症恶病症最令人衰弱的特征,并且有很少的治疗方法。本研究的目的是将L-亮氨酸和亮氨酸代谢物β-羟基-β-甲基丁酯(CA-HMB)对肌肉蛋白质代谢(invirogro和Invivo)的抗粘性效果进行比较。方法:在载体诱导鼠腺癌16肿瘤中的小鼠中进行研究,并在鼠C2 C12肌管中暴露于蛋白水解诱导因子,脂多糖和血管紧张素II。结果:亮氨酸和HMB均发现蛋白质诱导因子,脂多糖和血管紧张素II诱导的鼠霉素中蛋白质降解的增加和蛋白质合成的增加。然而,HMB比亮氨酸更有效,因为50μm的HMB产生的效果与1mm的亮氨酸相同。亮氨酸和HMB均可通过肌肉裂解物中蛋白酶体的功能(Chymotrypsin)酶活性,以及​​结构/酶蛋白酶体亚基的蛋白质水平的蛋白质水平的蛋白质水平(20 S和19 s)和泛素连接酶(Murf1和Mafbx)。载有鼠腺癌16颗粒的监管研究表明,低剂量的Ca-HMB(0.25g / kg),比亮氨酸(1g / kg)更有效,在4-D期间衰减体重损失。结论:这些结果有利于在高剂量亮氨酸上使用Ca-HMB治疗癌症恶病症的临床可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号